Results 31 to 40 of about 296,327 (357)

Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Whether coronary artery disease (CAD) is a significant risk factor for heart failure (HF) with preserved ejection fraction (HFpEF) is unclear. Methods and Results Among 9902 participants in the ARIC (Atherosclerosis Risk in Communities) study,
Jenine E. John, Brian Claggett, Hicham Skali, Scott D. Solomon, Jonathan W. Cunningham, Kunihiro Matsushita, Suma H. Konety, Dalane W. Kitzman, Thomas H. Mosley, Donald Clark, Patricia P. Chang, Amil M. Shah   +11 more
doaj   +1 more source

SERUM LEVEL OF ADVANCED OXIDATION PROTEIN PRODUCTS AND THE ACTIVITY OF SUPEROXIDE DISMUTASE AS THE MARKERS OF OXIDATIVE STRESS IN PATIENTS WITH CHRONIC HEART FAILURE

Кубанский научный медицинский вестник, 2019
Aim. The present work was aimed at studying and analysing the serum level of advanced oxidation protein products (AOPPs) and the total superoxide dismutase activity (total SOD) in patients with chronic heart failure (CHF) with a preserved and low left ...
Ekaterina A. Polunina
doaj   +1 more source

Cardiovascular magnetic resonance of cardiac function and myocardial mass in preterm infants: a preliminary study of the impact of patent ductus arteriosus [PDF]

, 2014
BackgroundMany pathologies seen in the preterm population are associated with abnormal blood supply, yet robust evaluation of preterm cardiac function is scarce and consequently normative ranges in this population are limited.
Alan M Groves, Anna E Finnemore, Anthony David Edwards, Anthony N Price, David J Cox, Giuliana Durighel, Joseph V Hajnal, Kathryn M Broadhouse   +7 more
core   +2 more sources

Beyond initial recovery: Heart failure with transient <i>vs</i> sustained improvement in left ventricular ejection fraction. [PDF]

World J Cardiol
Kaddoura R, Chapra A, Shah J, Izham M, Singh R, Alsadi H, Al-Amri M, Hamamyh T, Fallouh M, Elasad F, Abdelghani M, Alsaadi Alyafei S, Badr A, Patel A.   +13 more
europepmc   +2 more sources

Isosorbide dinitrate, with or without hydralazine, does not reduce wave reflections, left ventricular hypertrophy, or myocardial fibrosis in patients with heart failure with preserved ejection fraction [PDF]

, 2017
Background-Wave reflections, which are increased in patients with heart failure with preserved ejection fraction, impair diastolic function and promote pathologic myocardial remodeling.
Akers, Scott, Beraun, Melissa, Chirinos, Julio A., Chittams, Jesse, Haines, Philip G., Koppula, Maheswara R., Rawat, Deepa, Segers, Patrick, Shiva-Kumar, Prithvi, Soto-Calderon, Haideliza, Townsend, Raymond R., Varakantam, Swapna, Witschey, Walter R., Zamani, Payman   +13 more
core   +1 more source

The relationship between left ventricular wall thickness, myocardial shortening and ejection fraction in hypertensive heart disease:insights from cardiac magnetic resonance: LVH independently augments EF in hypertension [PDF]

, 2016
Hypertensive heart disease is often associated with a preserved left ventricular ejection fraction despite impaired myocardial shortening. The authors investigated this paradox in 55 hypertensive patients (52±13 years, 58% male) and 32 age‐ and sex ...
Bucciarelli-Ducci, Chiara, Burchell, Amy E, Dastidar, Amardeep Ghosh, Hamilton, Mark C K, Hart, Emma C, MacIver, David H, Manghat, Nathan E, Nightingale, Angus K, Paton, Julian F R, Ratcliffe, Laura E K, Rodrigues, Jonathan C L, Rohan, Stephen, Szantho, Gergely, Trickey, Adam   +13 more
core   +2 more sources

Can NT-proBNP Levels Be an Early Biomarker of Reduced Left Ventricular Ejection Fraction in Preterm Infants?

Children, 2022
Background/Objective: N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a cardiac natriuretic hormone that cardiomyocytes release in response to ventricular stretch.
Ya-Lan Lin, Yi-Li Hung, Chung-Min Shen, Yung-Chuan Chen, Wu-Shiun Hsieh   +4 more
doaj   +1 more source

Effects of vildagliptin on ventricular function in patients with type 2 diabetes mellitus and heart failure: a randomized placebo-controlled trial [PDF]

, 2017
Objectives: This study sought to examine the safety of the dipeptidyl peptidase-4 inhibitor, vildagliptin, in patients with heart failure and reduced ejection fraction.
Bolli, Geremia B., Kothny, Wolfgang, Kozlovski, Plamen, Krum, Henry, Lewsey, James D., Lukashevich, Valentina, McMurray, John J.V., Ponikowski, Piotr   +7 more
core   +2 more sources

Silent Cerebral Infarctions with Reduced, Mid-Range and Preserved Ejection Fraction in Patients with Heart Failure

Arquivos Brasileiros de Cardiologia
Heart failure predisposes to an increased risk of silent cerebral infarction, and data related to left ventricular ejection fraction are still limited.
Márcia Maria Carneiro Oliveira, Elieusa e Silva Sampaio, Jun Ramos Kawaoka, Maria Amélia Bulhões Hatem, Edmundo José Nassri Câmara, André Maurício Souza Fernandes, Jamary Oliveira-Filho, Roque Aras   +7 more
doaj   +1 more source

Heart Failure With Normal Left Ventricular Ejection Fraction

Journal of the American College of Cardiology, 2009
It is estimated that approximately 50% of the heart failure population has a normal left ventricular ejection fraction, a complex broadly referred to as heart failure with normal left ventricular ejection fraction (HFNEF). While these patients have been considered in epidemiologic studies and clinical trials to represent a single pool of patients ...
Maeder, Micha T., Kaye, David M.
openaire   +2 more sources